Skip to content

Impact of Obesity on Post-operative Cognitive Dysfunction: Role of Adipose Tissue

Impact of Obesity on Post-operative Cognitive Dysfunction: Role of Adipose Tissue

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04907565
Acronym
ODCOTA
Enrollment
115
Registered
2021-05-28
Start date
2021-09-21
Completion date
2025-03-30
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Impairment, Obesity, Post-Operative Confusion

Keywords

Obesity, Post-operative cognitive dysfunction, Inflammation, Inflammatory cytokines

Brief summary

This research aims at describing the relationship between white adipose tissue inflammation and post-operative cognitive dysfunctions.The possible link between inflammatory cytokines secretions of the white adipose tissue of a surgical wound and the arising of patient's cognitive dysfunction in the post-operative course will be investigated. The hypothesis is that obese patient's inflammation of the white adipose tissue leads to cognitive dysfunction.

Detailed description

The postoperative cognitive dysfunctions (POCD) are characterized by delirium and cognitive impairment. The delirium is defined by an acute altered attention with a fluctuating course. The post-operative cognitive impairment involves the early alteration of different functions including memory, attention and cognitive flexibility. POCD have a major impact in patient's morbidity. They are linked to the systemic inflammation induced by the surgical wound. The systemic inflammation leads to the rupture of the brain-blood barrier and to hippocampal inflammation. As hippocampus mediates the principal cognitive functions, hippocampal inflammation leads to POCD. Orthopedic and cardiac surgery are particularly concerned. Obesity is growing condition in the French population. It is linked to chronic systemic inflammation and altered cognitive functions. We think that obese people may present a susceptibility to POCD because of the pre-operative systemic inflammation.

Interventions

BIOLOGICALBlood sampling

4 tubes of 7 mL of blood will be collected

BIOLOGICALwhite adipose tissue sampling

At the beginning of the surgery, samples of white adipose tissue from the surgical wound will be collected.

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* patient about to receive a hip arthroplasty under general anesthesia, elective cardiac surgery with cardiopulmonary bypass, * patient with a MMSE score \> or = 20(/30), * patient able to give informed consent

Exclusion criteria

* emergency surgery, or surgery in a septic context, * patient with a known dementia or altered MMSE score (under 20)

Design outcomes

Primary

MeasureTime frameDescription
Arising of POCD measured by a composite criterionday 5 after surgery2 points Mini-Mental State Examination (MMSE) score decrease compared to the pre-operative score, and/or appearance of a delirium tracked down every day by the Confusion Assessment Method (CAM) during the hospital course.

Secondary

MeasureTime frameDescription
Variation of inflammatory cytokine levels from patient's plasma and patient's white adipose tissue (extract from a controlled medium).Day 0 and day 5 after surgeryinflammatory cytokine levels will be measured in plasma and adipose tissue, and compared.
Identification of a linked between inflammatory cytokine levels and the appearance of POCD.day 5 after surgeryinflammatory cytokine levels will be measured in plasma and adipose tissue, and correlated with appearance of POCD
Peri-operative variations of the protein S100B, an autonomy scale (IADL) and a quality of life scale (EQ5D).day 5 after surgeryprotein S100B levels will be measured in plasma and adipose tissue, and correlated with scores of autonomy scale (IADL) and quality of life scale (EQ5D).

Countries

France

Contacts

PRINCIPAL_INVESTIGATORFrançois Labaste, MD, PhD

University Hospital, Toulouse

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026